Back to top

BioLine Rx (BLRX) Catches Eye: Stock Adds 5.2% in Session
July 21, 2017

Read MoreHide Full Article

BioLine Rx Ltd (BLRX - Free Report) was a big mover last session, as the company saw its shares rise over 5% on the day. The move also led to far more shares changing hands than in a normal session.This breaks the recent trend for the company as the stock is now trading above the volatile price range of $0.81 to $0.95 in the past one-month time frame.

None of the estimates for the stock has been revised in the last 30 days and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Currently, BioLine Rx carries a Zacks Rank #4 (Sell), while the Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Alcobra Ltd. (ADHD - Free Report) , which sports a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BLRX going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?                       

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge. With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research. It's not the one you think. See This Ticker Free >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


BioLineRx Ltd. (BLRX) - free report >>

Alcobra Ltd. (ADHD) - free report >>


More from Zacks Tale of the Tape

You May Like